Keros Therapeutics Inc. (KROS)
NASDAQ · Healthcare
Keros Therapeutics Inc. Cash on Hand 2019–2025
Keros Therapeutics Inc. annual cash on hand history from 2019 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Keros Therapeutics Inc. cash on hand as of December 31, 2025: 287.4M, a 48.67% decrease year-over-year.
- Keros Therapeutics Inc. cash on hand for 2025 were 287.4M, a 48.67% decrease from 2024.
- Keros Therapeutics Inc. cash on hand for 2024 were 559.9M, a 69.09% increase from 2023.
- Keros Therapeutics Inc. cash on hand for 2023 were 331.1M, a 18.67% increase from 2022.
- Keros Therapeutics Inc. cash on hand for 2022 were 279.0M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Keros Therapeutics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $287 |
| 2024 | $560 |
| 2023 | $331 |
| 2022 | $279 |
| 2021 | $230 |
| 2020 | $266 |
| 2019 | $7 |
Keros Therapeutics Inc. Cash on Hand — FAQ
Keros Therapeutics Inc. (KROS) cash on hand over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KROS's cash on hand history?
The chart and table above show Keros Therapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.